a request. people may apply clinical trial data through a new website.
clinicaltrialstudytransparency.com/Janssen Pharmaceuticals
Johnson & Johnson announced an unusual partnership today with Yale University, where he will share the raw data most of its clinical trials. The project of Yale University Open Data Access (aptly nicknamed YODA) will "review requests from investigators and physicians seeking access to anonymous data on clinical trials of Janssen Pharmaceutical Companies of Johnson & Johnson" wrote the company in a press release. YODA The team will then decide that researchers can access the information for their own studies.
The announcement caused a small explosion of new. Forbes wrote that "First, it will only include products division of drugs, but it will be expanded to include devices and consumer products." Janssen Pharmaceuticals extend the range, including pills for acid reflux, schizophrenia, pain, and birth control, among others. the data to share with YODA go well beyond the study design and results, and include de-identified information on each volunteer. YODA is led by Harlan Krumholz, a cardiologist who has long pushed for more access to data in clinical research. (in 2010, Forbes named him "the Doctor stronger you never heard of. ")
Johnson & Johnson, of course, will get to decide what it sends to New Haven, even if it is put into wide release pledge. It's a bit in contrast to a brewing controversy in Europe where drug regulators hope to release the same kind of raw data submitted to it by pharmaceutical companies. This effort has been met with repression and prosecution. But it is part of a broader change in the US and Europe, where some researchers and regulators are increasingly frustrated by the secrecy surrounding many drug trials, and want to get the information outdoors.
0 Komentar